Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 70/100

BD to Present at the 6th Annual Evercore ISI HealthCONx Conference BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 6th Annual...

Key Takeaway: Becton, Dickinson and Company (BD) has announced its participation in the 6th Annual Evercore ISI HealthCONx Conference, scheduled for November 28, 2023. The presentation will be accessible via a live webcast, with a replay available post-event. BD is recognized as a leading global medical technology company, emphasizing its dedication to improving healthcare through innovative technologies and solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is participating in a prominent industry conference, enhancing visibility.
  • The company's commitment to innovation and improving healthcare delivery is highlighted.
  • Presence on a global scale with a focus on impactful health solutions.

Full Press Release Details

FRANKLIN LAKES, N.J. , Nov. 14, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will present at the 6 th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023 at 8:20 am Eastern Time .
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com . A replay of the event will be available on the same webpage following its conclusion.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD , please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .
Contacts:
Media : Investors :
Troy Kirkpatrick Greg Rodetis
VP, Public Relations SVP, Head of Investor Relations
858.617.2361 201.847.6875
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will BD present at the Evercore ISI HealthCONx Conference?

BD will present on November 28, 2023, at 8:20 am Eastern Time.

Where can I watch BD's conference presentation live?

The live presentation can be accessed on BD's investor relations website.

Will there be a replay of BD's conference presentation?

Yes, a replay will be available on the investor relations webpage after the event.

What is BD's mission in healthcare?

BD aims to enhance medical discovery, diagnostics, and care delivery globally.

Last updated: Nov 14, 2023